Skip to main content

Dryice Myxalytics

29 CVEs product

Monthly

CVE-2025-52656 Oct 03, 19:15 HIGH This Week

HCL MyXalytics: 6.6.  is affected by Mass Assignment vulnerability. Mass Assignment occurs when user input is automatically bound to application objects without proper validation or access controls, potentially allowing unauthorized modification of sensitive fields.

Information Disclosure Dryice Myxalytics
NVD
CVSS 3.1
7.6
EPSS
0.1%
CVE-2025-52654 Oct 03, 19:15 MEDIUM This Month

HCL MyXalytics v6.6 is affected by an HTML Injection. This issue occurs when untrusted input is included in the output without proper handling, potentially allowing unauthorized content injection and manipulation.

XSS Dryice Myxalytics
NVD
CVSS 3.1
4.6
EPSS
0.0%
CVE-2025-52653 Oct 03, 18:15 HIGH This Week

HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.

XSS Dryice Myxalytics
NVD
CVSS 3.1
7.6
EPSS
0.0%
CVE-2024-42178 Apr 17, 22:15 LOW Monitor

HCL MyXalytics is affected by a failure to restrict URL access vulnerability. Rated low severity (CVSS 2.5). No vendor patch available.

Authentication Bypass Dryice Myxalytics
NVD
CVSS 3.1
2.5
EPSS
0.2%
CVE-2024-42177 Apr 17, 20:15 LOW Monitor

HCL MyXalytics is affected by SSL∕TLS Protocol affected with BREACH & LUCKY13 vulnerabilities. Rated low severity (CVSS 2.6), this vulnerability is remotely exploitable. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
CVSS 3.1
2.6
EPSS
0.1%
CVE-2024-42176 Mar 19, 15:15 LOW Monitor

HCL MyXalytics is affected by concurrent login vulnerability. Rated low severity (CVSS 2.6), this vulnerability is remotely exploitable. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
CVSS 3.1
2.6
EPSS
0.1%
CVE-2024-42181 Jan 12, 22:15 LOW Monitor

HCL MyXalytics is affected by a cleartext transmission of sensitive information vulnerability. Rated low severity (CVSS 1.6). No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
CVSS 3.1
1.6
EPSS
0.1%
CVE-2024-42180 Jan 12, 22:15 LOW Monitor

HCL MyXalytics is affected by a malicious file upload vulnerability. Rated low severity (CVSS 1.6). No vendor patch available.

File Upload Dryice Myxalytics
NVD
CVSS 3.1
1.6
EPSS
0.2%
CVE-2024-42179 Jan 12, 22:15 LOW Monitor

HCL MyXalytics is affected by sensitive information disclosure vulnerability. Rated low severity (CVSS 2.0), this vulnerability is remotely exploitable. No vendor patch available.

Microsoft Information Disclosure Dryice Myxalytics
NVD
CVSS 3.1
2.0
EPSS
0.2%
CVE-2024-42175 Jan 11, 08:15 LOW Monitor

HCL MyXalytics is affected by a weak input validation vulnerability. Rated low severity (CVSS 2.6), this vulnerability is remotely exploitable. No vendor patch available.

Buffer Overflow XSS SQLi Dryice Myxalytics
NVD
CVSS 3.1
2.6
EPSS
0.2%
CVE-2024-42174 Jan 11, 07:15 LOW Monitor

HCL MyXalytics is affected by username enumeration vulnerability. Rated low severity (CVSS 3.7), this vulnerability is remotely exploitable, no authentication required. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
CVSS 3.1
3.7
EPSS
0.3%
CVE-2024-42173 Jan 11, 07:15 MEDIUM Monitor

HCL MyXalytics is affected by an improper password policy implementation vulnerability. Rated medium severity (CVSS 4.8), this vulnerability is remotely exploitable. No vendor patch available.

Brute Force Information Disclosure Dryice Myxalytics
NVD
CVSS 3.1
4.8
EPSS
0.2%
CVE-2024-42172 Jan 11, 07:15 MEDIUM This Month

HCL MyXalytics is affected by broken authentication. Rated medium severity (CVSS 5.3), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Authentication Bypass Dryice Myxalytics
NVD
CVSS 3.1
5.3
EPSS
0.2%
CVE-2024-42171 Jan 11, 07:15 MEDIUM This Month

HCL MyXalytics is affected by a session fixation vulnerability. Rated medium severity (CVSS 6.4), this vulnerability is remotely exploitable. No vendor patch available.

Information Disclosure Session Fixation Dryice Myxalytics
NVD
CVSS 3.1
6.4
EPSS
0.2%
CVE-2024-42170 Jan 11, 07:15 MEDIUM This Month

HCL MyXalytics is affected by a session fixation vulnerability. Rated medium severity (CVSS 6.8), this vulnerability is remotely exploitable, no authentication required. No vendor patch available.

Information Disclosure Session Fixation Dryice Myxalytics
NVD
CVSS 3.1
6.8
EPSS
0.2%
CVE-2024-42169 Jan 11, 03:15 HIGH This Month

HCL MyXalytics is affected by insecure direct object references. Rated high severity (CVSS 7.1), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Authentication Bypass Dryice Myxalytics
NVD
CVSS 3.1
7.1
EPSS
0.3%
CVE-2024-42168 Jan 11, 03:15 HIGH This Month

HCL MyXalytics is affected by out-of-band resource load (HTTP) vulnerability. Rated high severity (CVSS 8.9), this vulnerability is remotely exploitable, no authentication required. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
CVSS 3.1
8.9
EPSS
0.3%
CVE-2023-50344 Jan 03, 03:15 MEDIUM This Month

HCL DRYiCE MyXalytics is impacted by improper access control (Unauthenticated File Download) vulnerability. Rated medium severity (CVSS 5.4), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Authentication Bypass Dryice Myxalytics
NVD
CVSS 3.1
5.4
EPSS
0.2%
CVE-2023-50343 Jan 03, 03:15 HIGH This Week

HCL DRYiCE MyXalytics is impacted by an Improper Access Control (Controller APIs) vulnerability. Rated high severity (CVSS 8.3), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Authentication Bypass Dryice Myxalytics
NVD
CVSS 3.1
8.3
EPSS
0.1%
CVE-2023-50342 Jan 03, 03:15 HIGH This Week

HCL DRYiCE MyXalytics is impacted by an Insecure Direct Object Reference (IDOR) vulnerability. Rated high severity (CVSS 7.1), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Authentication Bypass Dryice Myxalytics
NVD
CVSS 3.1
7.1
EPSS
0.2%
CVE-2023-50341 Jan 03, 03:15 HIGH This Week

HCL DRYiCE MyXalytics is impacted by Improper Access Control (Obsolete web pages) vulnerability. Rated high severity (CVSS 7.6), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Authentication Bypass Dryice Myxalytics
NVD
CVSS 3.1
7.6
EPSS
0.1%
CVE-2023-45724 Jan 03, 03:15 HIGH This Week

HCL DRYiCE MyXalytics product is impacted by unauthenticated file upload vulnerability. Rated high severity (CVSS 8.2), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

File Upload Dryice Myxalytics
NVD
CVSS 3.1
8.2
EPSS
0.2%
CVE-2023-45723 Jan 03, 03:15 HIGH This Week

HCL DRYiCE MyXalytics is impacted by path traversal vulnerability which allows file upload capability. Rated high severity (CVSS 7.6), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

File Upload Path Traversal Dryice Myxalytics
NVD
CVSS 3.1
7.6
EPSS
0.1%
CVE-2023-45722 Jan 03, 03:15 HIGH This Week

HCL DRYiCE MyXalytics is impacted by path traversal arbitrary file read vulnerability because it uses external input to construct a pathname that is intended to identify a file or directory that is. Rated high severity (CVSS 8.8), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Path Traversal Dryice Myxalytics
NVD
CVSS 3.1
8.8
EPSS
0.1%
CVE-2023-50351 Jan 03, 02:15 HIGH This Week

HCL DRYiCE MyXalytics is impacted by the use of an insecure key rotation mechanism which can allow an attacker to compromise the confidentiality or integrity of data. Rated high severity (CVSS 8.2), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
CVSS 3.1
8.2
EPSS
0.0%
CVE-2023-50350 Jan 03, 02:15 HIGH This Week

HCL DRYiCE MyXalytics is impacted by the use of a broken cryptographic algorithm for encryption, potentially giving an attacker ability to decrypt sensitive information. Rated high severity (CVSS 8.2), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
CVSS 3.1
8.2
EPSS
0.0%
CVE-2023-50348 Jan 03, 02:15 LOW Monitor

HCL DRYiCE MyXalytics is impacted by an improper error handling vulnerability. Rated low severity (CVSS 3.1), this vulnerability is remotely exploitable. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
CVSS 3.1
3.1
EPSS
0.2%
CVE-2023-50346 Jan 03, 02:15 LOW Monitor

HCL DRYiCE MyXalytics is impacted by an information disclosure vulnerability. Rated low severity (CVSS 3.1), this vulnerability is remotely exploitable. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
CVSS 3.1
3.1
EPSS
0.2%
CVE-2023-50345 Jan 03, 02:15 LOW Monitor

HCL DRYiCE MyXalytics is impacted by an Open Redirect vulnerability which could allow an attacker to redirect users to malicious sites, potentially leading to phishing attacks or other security. Rated low severity (CVSS 3.7), this vulnerability is remotely exploitable, no authentication required. No vendor patch available.

Open Redirect Dryice Myxalytics
NVD
CVSS 3.1
3.7
EPSS
0.2%
EPSS 0% CVSS 7.6
HIGH This Week

HCL MyXalytics: 6.6.  is affected by Mass Assignment vulnerability. Mass Assignment occurs when user input is automatically bound to application objects without proper validation or access controls, potentially allowing unauthorized modification of sensitive fields.

Information Disclosure Dryice Myxalytics
NVD
EPSS 0% CVSS 4.6
MEDIUM This Month

HCL MyXalytics v6.6 is affected by an HTML Injection. This issue occurs when untrusted input is included in the output without proper handling, potentially allowing unauthorized content injection and manipulation.

XSS Dryice Myxalytics
NVD
EPSS 0% CVSS 7.6
HIGH This Week

HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.

XSS Dryice Myxalytics
NVD
EPSS 0% CVSS 2.5
LOW Monitor

HCL MyXalytics is affected by a failure to restrict URL access vulnerability. Rated low severity (CVSS 2.5). No vendor patch available.

Authentication Bypass Dryice Myxalytics
NVD
EPSS 0% CVSS 2.6
LOW Monitor

HCL MyXalytics is affected by SSL∕TLS Protocol affected with BREACH & LUCKY13 vulnerabilities. Rated low severity (CVSS 2.6), this vulnerability is remotely exploitable. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
EPSS 0% CVSS 2.6
LOW Monitor

HCL MyXalytics is affected by concurrent login vulnerability. Rated low severity (CVSS 2.6), this vulnerability is remotely exploitable. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
EPSS 0% CVSS 1.6
LOW Monitor

HCL MyXalytics is affected by a cleartext transmission of sensitive information vulnerability. Rated low severity (CVSS 1.6). No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
EPSS 0% CVSS 1.6
LOW Monitor

HCL MyXalytics is affected by a malicious file upload vulnerability. Rated low severity (CVSS 1.6). No vendor patch available.

File Upload Dryice Myxalytics
NVD
EPSS 0% CVSS 2.0
LOW Monitor

HCL MyXalytics is affected by sensitive information disclosure vulnerability. Rated low severity (CVSS 2.0), this vulnerability is remotely exploitable. No vendor patch available.

Microsoft Information Disclosure Dryice Myxalytics
NVD
EPSS 0% CVSS 2.6
LOW Monitor

HCL MyXalytics is affected by a weak input validation vulnerability. Rated low severity (CVSS 2.6), this vulnerability is remotely exploitable. No vendor patch available.

Buffer Overflow XSS SQLi +1
NVD
EPSS 0% CVSS 3.7
LOW Monitor

HCL MyXalytics is affected by username enumeration vulnerability. Rated low severity (CVSS 3.7), this vulnerability is remotely exploitable, no authentication required. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
EPSS 0% CVSS 4.8
MEDIUM Monitor

HCL MyXalytics is affected by an improper password policy implementation vulnerability. Rated medium severity (CVSS 4.8), this vulnerability is remotely exploitable. No vendor patch available.

Brute Force Information Disclosure Dryice Myxalytics
NVD
EPSS 0% CVSS 5.3
MEDIUM This Month

HCL MyXalytics is affected by broken authentication. Rated medium severity (CVSS 5.3), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Authentication Bypass Dryice Myxalytics
NVD
EPSS 0% CVSS 6.4
MEDIUM This Month

HCL MyXalytics is affected by a session fixation vulnerability. Rated medium severity (CVSS 6.4), this vulnerability is remotely exploitable. No vendor patch available.

Information Disclosure Session Fixation Dryice Myxalytics
NVD
EPSS 0% CVSS 6.8
MEDIUM This Month

HCL MyXalytics is affected by a session fixation vulnerability. Rated medium severity (CVSS 6.8), this vulnerability is remotely exploitable, no authentication required. No vendor patch available.

Information Disclosure Session Fixation Dryice Myxalytics
NVD
EPSS 0% CVSS 7.1
HIGH This Month

HCL MyXalytics is affected by insecure direct object references. Rated high severity (CVSS 7.1), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Authentication Bypass Dryice Myxalytics
NVD
EPSS 0% CVSS 8.9
HIGH This Month

HCL MyXalytics is affected by out-of-band resource load (HTTP) vulnerability. Rated high severity (CVSS 8.9), this vulnerability is remotely exploitable, no authentication required. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
EPSS 0% CVSS 5.4
MEDIUM This Month

HCL DRYiCE MyXalytics is impacted by improper access control (Unauthenticated File Download) vulnerability. Rated medium severity (CVSS 5.4), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Authentication Bypass Dryice Myxalytics
NVD
EPSS 0% CVSS 8.3
HIGH This Week

HCL DRYiCE MyXalytics is impacted by an Improper Access Control (Controller APIs) vulnerability. Rated high severity (CVSS 8.3), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Authentication Bypass Dryice Myxalytics
NVD
EPSS 0% CVSS 7.1
HIGH This Week

HCL DRYiCE MyXalytics is impacted by an Insecure Direct Object Reference (IDOR) vulnerability. Rated high severity (CVSS 7.1), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Authentication Bypass Dryice Myxalytics
NVD
EPSS 0% CVSS 7.6
HIGH This Week

HCL DRYiCE MyXalytics is impacted by Improper Access Control (Obsolete web pages) vulnerability. Rated high severity (CVSS 7.6), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Authentication Bypass Dryice Myxalytics
NVD
EPSS 0% CVSS 8.2
HIGH This Week

HCL DRYiCE MyXalytics product is impacted by unauthenticated file upload vulnerability. Rated high severity (CVSS 8.2), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

File Upload Dryice Myxalytics
NVD
EPSS 0% CVSS 7.6
HIGH This Week

HCL DRYiCE MyXalytics is impacted by path traversal vulnerability which allows file upload capability. Rated high severity (CVSS 7.6), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

File Upload Path Traversal Dryice Myxalytics
NVD
EPSS 0% CVSS 8.8
HIGH This Week

HCL DRYiCE MyXalytics is impacted by path traversal arbitrary file read vulnerability because it uses external input to construct a pathname that is intended to identify a file or directory that is. Rated high severity (CVSS 8.8), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Path Traversal Dryice Myxalytics
NVD
EPSS 0% CVSS 8.2
HIGH This Week

HCL DRYiCE MyXalytics is impacted by the use of an insecure key rotation mechanism which can allow an attacker to compromise the confidentiality or integrity of data. Rated high severity (CVSS 8.2), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
EPSS 0% CVSS 8.2
HIGH This Week

HCL DRYiCE MyXalytics is impacted by the use of a broken cryptographic algorithm for encryption, potentially giving an attacker ability to decrypt sensitive information. Rated high severity (CVSS 8.2), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
EPSS 0% CVSS 3.1
LOW Monitor

HCL DRYiCE MyXalytics is impacted by an improper error handling vulnerability. Rated low severity (CVSS 3.1), this vulnerability is remotely exploitable. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
EPSS 0% CVSS 3.1
LOW Monitor

HCL DRYiCE MyXalytics is impacted by an information disclosure vulnerability. Rated low severity (CVSS 3.1), this vulnerability is remotely exploitable. No vendor patch available.

Information Disclosure Dryice Myxalytics
NVD
EPSS 0% CVSS 3.7
LOW Monitor

HCL DRYiCE MyXalytics is impacted by an Open Redirect vulnerability which could allow an attacker to redirect users to malicious sites, potentially leading to phishing attacks or other security. Rated low severity (CVSS 3.7), this vulnerability is remotely exploitable, no authentication required. No vendor patch available.

Open Redirect Dryice Myxalytics
NVD

This site uses cookies essential for authentication and security. No tracking or analytics cookies are used. Privacy Policy